Low price high purity 541550-19-0 Apilimod (Synonyms: STA 5326) in stock CAS NO.541550-19-0
- FOB Price: USD: 480.00-500.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T,
- Available Specifications:
gram (1-5)Gramgram (5-10)Gram
- Product Details
Keywords
- 541550-19-0
- 541550-19-0 Apilimod (Synonyms: STA 5326)
- Low price high purity 541550-19-0 Apilimod (Synonyms: STA 5326)
Quick Details
- ProName: Low price high purity 541550-19-0 Apil...
- CasNo: 541550-19-0
- Molecular Formula: C??H??N?O?
- Appearance: powder
- Application: Apilimod is a potent IL-12/IL-23 inhib...
- DeliveryTime: 3-5 days after received the 100% payme...
- PackAge: by bottle
- Port: Wuhan
- ProductionCapacity: 10 Gram/Week
- Purity: >=98%
- Storage: 4°C for 2 years and -20°C for 3 years
- Transportation: By courier ( Fedex, UPS, DHL, EMS, SF ...
- LimitNum: 1 Gram
- Solvent:: DMSO : ≥ 46 mg/mL (109.92 mM)
Superiority
Low price high purity 541550-19-0 Apilimod (Synonyms: STA 5326) in stock
Apilimod is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 with IC50s of 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively.
Molecular Weight |
418.49 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Formula |
C??H??N?O? |
||||||||||||
CAS No. |
541550-19-0 |
||||||||||||
SMILES |
CC1=CC=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC4=CC=CC=N4)=N2)=C1 |
||||||||||||
Shipping |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
Storage |
|
We have more than 10g stock at hand with very low price and with good quality and if you need more we can make Customized specifically for you.
Details
Wuhan Jonk Biological technology Co.,Ltd is a leading supplier of phytochemical reference standards and small molecule compound for regulatory filing and quality testing or early stage R&D. We are professional in extraction, synthesis and purification. With more than 5,000 products for sale, we serve the universal leading research institutes, universities, contract research organizations and large pharmaceutical and biotech companies sincerely .